(Vienna, 18.12.2020) Each year, the University of Natural Resources and Life Sciences (BOKU), Vienna awards the most outstanding invention. In 2020, the prize went to our co-inventors from the external module of CCRI´s Christian-Doppler Laboratory for Next Generation CAR T Cells, DI Michael Traxlmayr, PhD, and Charlotte Zajc, PhD, with…
CCRI Christian-Doppler Lab wins BOKU Invention of the Year 2020 Award
New method of Coronavirus Decontamination
(Vienna, 17.12.2020) Prof. Thomas Lion, MD, PhD, MSc, of St. Anna Children’s Cancer Research Institute in Vienna and Doc. Ing. Vladimir Scholtz, PhD, of the University of Chemistry and Technology in Prague, are selected for the first international FWF corona urgent funding. The focus of their research project is on…
Video: Early cancer diagnosis seems crucial in children with immune defect
(Vienna, 03.12.2020) CD27/CD70 deficiencies can lead to cancer in small children: “If diagnosed at an early stage, the majority of these patients are responsive to the hematopoietic stem cell treatment”, says Co-first author Sevgi Köstel Bal, MD, Phd, St. Anna Children's Cancer Research Institute (CCRI)’s, in a video statement on…
Cancer in children with rare inborn immune defect: High cure rate if treated early
(Vienna, 03.12.2020) New research data highlight a marked predisposition to lymphoma, a type of cancer, in children harboring specific gene mutations. A significant fraction of these rare mutations also cause inborn immune defects associated with recurrent infections. Collaborating closely with leading centers across the world, researchers investigated patients bearing recently…
Selected for funding: Training a new generation of childhood cancer scientists
(Vienna, 24.11.2020) St. Anna Children’s Cancer Research Institute is part of a European Marie Sklodowska-Curie Actions Innovative Training Network ITN. Being awarded with this grant, Prof. Heinrich Kovar, PhD, is looking forward to train an international PhD student within the VAGABOND program. The successful candidate will investigate druggable molecular pathways…
How cancer cells escape crowded tumors
(Vienna, 16.10.2020) When trapped in a crowded environment, cells of the human body try to escape. Scientists now discovered that it is the cell nucleus, which triggers the “evasion reflex”. This reflex is activated once cell compression exceeds the size of the nucleus. Published in the highly renowned journal Science,…
How to save lives: Caroline Hutter maps a rare childhood cancer entity
(Vienna, 29.09.2020) Caroline Hutter, MD, PhD, loves to solve tricky puzzles. One of them is Langerhans cell histiocytosis – a disease of which almost nothing was known until a few years ago. Hutter not only heads the Biology of Langerhans cell histiocytosis group at St. Anna Children's Cancer Research Institute,…
"Conquer childhood cancer with an army of upgraded immune cells!"
(Vienna, 21.09.2020) Priv.-Doz. René Geyeregger, PhD, is taking full risk on a promising research project. Because this is often the only way to create something groundbreaking. Something that helps children with cancer who no longer respond to current treatment. Geyeregger heads the Clinical Cell Biology and FACS Core Unit of…
Dream Job Childhood Cancer Scientist: "Always a step ahead of the tumor"
(Vienna, 14.09.2020) Sabine Taschner-Mandl, PhD, aims to achieve a long-term benefit for children with cancer via research. She heads the Tumor Biology group at St. Anna Children's Cancer Research Institute and, on the occasion of Childhood Cancer Awareness Month September, explains how she is pursuing her goal and what it…
Childhood Cancer Neuroblastoma: Not only DNA, it´s also the age that matters
(Vienna, 09.09.2020) Scientists at St. Anna Children's Cancer Research Institute provide an important new insight in neuroblastoma, the most common solid tumor in infants and young children: the influence of genome alterations on the course of disease in certain neuroblastomas depends also on age. The results, published in the renowned…